放射治疗市场份额报告| 2028 年趋势、规模和预测

  • Report Code : TIPMD00002668
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 217
Buy Now

【研究报告】预计放疗市场将从2020年的64.7478亿美元增至2028年的101.708亿美元;预计 2021 年至 2028 年复合年增长率为 5.9%。

市场洞察和分析师观点:

放射治疗,也称为放疗,是一种利用高能辐射瞄准并摧毁恶性(癌)细胞的医疗方法。它是癌症治疗的重要组成部分,用于治愈癌症、控制其生长或缓解症状。放射治疗通常涉及电离辐射,例如 X 射线或伽马射线,以攻击癌细胞并阻碍其生长和繁殖的能力。可以使用将辐射引导至癌变区域的机器进行外部治疗(外束放射治疗),也可以通过在体内受影响细胞附近插入放射源进行内部治疗(近距离放射治疗)。放射治疗的目标是向肿瘤提供精确目标剂量的放射线,最大限度地减少对周围健康组织的损害,同时最大限度地提高对癌细胞的作用。放射疗法与其他癌症治疗结合使用,例如手术和化疗。治疗时会仔细考虑癌症类型、分期和患者的整体健康状况。因此,放射治疗在癌症的综合管理中发挥着至关重要的作用,它提供了一种有效的局部治疗肿瘤的方法,同时努力保护健康组织并改善患者的预后。

增长动力和机遇:< /strong>

癌症患者病例的增加、政府和非政府对放射治疗研发的巨额投资是放射治疗市场增长的主要驱动力癌症治疗,以及降低医疗费用的日益增长的需求。世界上癌症患者的数量正在显着增加。据世界卫生组织 (WHO) 统计,癌症是全球第二大死亡原因,2022 年约有 1000 万人死亡。  在所有癌症类型中,乳腺癌被认为是最常见的癌症。全世界女性中最常见的癌症,其发病率在全球范围内不断增加。生活方式的改变、荷尔蒙失衡、遗传倾向和环境因素等因素导致乳腺癌患病率上升。根据美国癌症协会的数据,大约 5-10% 的恶性肿瘤是由父母遗传的基因引起的。已经发现了几种癌症易感基因。例如,遗传性癌症易感基因 BRCA1 和 BRCA2 的突变会增加患某些恶性肿瘤的风险,例如乳腺癌、卵巢癌和前列腺癌。

此外,乳腺癌是美国最常见的癌症类型之一。 Breastcancer.org 于 2022 年 1 月发布的一份报告指出,全国八分之一的女性(约 13%)将在一生中患上浸润性乳腺癌。据同一消息来源称,预计 2022 年美国女性将新增 287,850 例浸润性乳腺癌病例,以及 51,400 例新发非浸润性(原位)乳腺癌病例。预计将新增约 2,710 例男性浸润性乳腺癌病例。大约每 833 名男性中就有 1 人可能在一生中患上乳腺癌。随着乳腺癌病例的增加,越来越需要有效的靶向治疗来改善患者的治疗结果。这导致的研发活动激增。 乳腺癌发病率的上升凸显了放射治疗在这种常见恶性肿瘤的综合治疗中的重要作用。随着被诊断患有乳腺癌的人数持续增加,放射治疗已成为多学科癌症治疗方法中的重要方式。放射治疗在乳腺癌的治疗中发挥着关键作用,具有多种用途,例如根除残留癌细胞的术后治疗、术前缩小肿瘤的新辅助治疗以及降低癌症复发风险的辅助治疗。此外,放射治疗还可用于缓解晚期或转移性乳腺癌的症状并改善预后。

”根据类型、应用程序、最终用户和地区进行细分。 放射治疗市场大致分为全身放射治疗、外部放射治疗和内部放射治疗。放射治疗市场根据应用进行分类,如皮肤癌和唇癌、乳腺癌、前列腺癌、宫颈癌、肺癌等。放射治疗市场的最终用户部分大致分为医院、门诊和放射治疗中心等。 放射治疗市场根据地理位置分为北美(美国、加拿大和墨西哥)、欧洲(德国、法国、意大利、英国和欧洲其他地区)、亚太地区(澳大利亚) 、中国、日本、印度、韩国和亚太地区其他地区)、中东和非洲非洲(南非、沙特阿拉伯、阿联酋以及中东和非洲其他地区)以及南美和非洲中美洲(巴西、阿根廷以及南美洲和中美洲其他地区)

细分分析:

根据类型,放射治疗市场分为外部放射治疗、内部放射治疗和全身放射治疗。 2022年,放射治疗市场收入主要来自外照射放射治疗,所占份额最大。由于发达国家和发展中国家癌症发病率和患病率的上升、技术的发展以及医疗保健支出的增加,全球放射治疗市场预计将在预测期内增长。为了改善患者的治疗效果,癌症中心正在扩大外照射放射治疗的可用性,包括立体定向放射外科、调强放射治疗 (IMRT) 和 3D 适形放射治疗。由于这些治疗选择,医疗保健公司可以扩大癌症放射治疗的研发工作。

根据癌症细分市场,放射治疗市场被细分皮肤癌和唇癌、乳腺癌、前列腺癌、宫颈癌、肺癌等。皮肤癌,包括鳞状细胞癌、黑色素瘤和基底细胞癌,主要是由于暴露在紫外线 (UV) 下而在皮肤细胞中形成的。唇癌的三个主要原因是吸烟、免疫系统受损和紫外线辐射。预计在整个预测期间,皮肤癌和唇癌部分将显着增长。皮肤癌和唇癌发病率的上升、大量的研发管线、放射技术的改进、对放射治疗等非侵入性癌症治疗的需求不断增长以及全球范围内放射治疗服务的扩大是推动该细分市场增长的一些因素。例如,根据美国癌症协会2023年1月的数据,到2023年底,美国将检测出97,610例黑色素瘤,其中男性58,120例,女性39,490例。因此,对辐射设备的需求将相当大由于皮肤癌和唇癌患病率的增加,出于治疗原因,这将推动市场扩张。

根据最终用户,放射治疗市场被分类进入医院、门诊和放射治疗中心等。在整个预测期内,医院部门预计将占据重要的全球市场份额。这是因为癌症患者数量增加以及医院使用不同放射治疗的增加。

区域分析:

根据地理位置,全球放射治疗市场分为五个关键区域:北美、欧洲、亚太地区、南美和中东地区。中美洲、中东和非洲非洲。

预计在整个预测期内,北美放射治疗市场将出现显着扩张。癌症发病率和患病率的上升、该地区的大公司以及创新产品的推出都有助于市场的扩张。根据 2023 年 1 月更新的数据,美国癌症协会在美国女性中最常见的癌症是乳腺癌。乳腺癌占美国每年新诊断的所有女性癌症的三分之一,即 30%。该消息来源预计,到 2023 年底,女性将新诊断出 297,790 例浸润性乳腺癌和 55,720 例导管原位癌 (DCIS)。预计癌症负担将推动国家对放射治疗的需求。因此,该国的高癌症发病率和患病率需要开发先进的放射治疗方法,这也有望推动该地区的整体市场扩张。

此外,主要区域参与者积极参与与放射治疗相关的多项进展,推动了区域市场的扩张。例如,SkinCure Oncology于2021年9月宣布,图像引导浅表放射治疗(IGSRT)治疗鳞状细胞癌(SCC)和基底细胞癌(BCC)的临床试验获得了积极数据(治愈率99.3%)。此外,GE Healthcare 于 2021 年 10 月在美国放射肿瘤学会 2021 年活动中展示了 15 种尖端的多模式放射治疗解决方案,以加强以患者为中心的护理并推进精准医疗。由于最近的这些突破,预计全国对放射治疗的需求将会增加,从而推动整个区域市场的扩张。

行业发展和未来机遇:

全球放射治疗市场主要参与者采取的各种举措如下:

2023 年 5 月,GE HealthCare 推出了三款新产品,突出放射肿瘤治疗路径,其中包括智能放射治疗 (IRT)、自动分割和升级版磁共振(MR) 放射治疗套件(AIR 开放式线圈套件)。为了帮助患者过上尽可能健康的生活,这些尖端解决方案中的每一个都将在 2023 年欧洲治疗放射学和肿瘤学协会大会上展示,其目的是使医生能够通过给予患者提供最高水平的个性化护理他们可以访问做出明智决策所需的数据、技术和诊断。

2023 年 2 月,RefleXion Medical 的 SCINTIX 生物引导放射治疗获得美国 FDA 批准,这是一种针对早期和晚期癌症的尖端治疗方法。< /span>

竞争格局和主要公司:

全球放射治疗市场的一些知名企业是GE Healthcare、GE Healthcare、Elekta、ViewRay Technologies, Inc.、Accuray Incorporated、Isoray Inc.、Hitachi, Ltd.、ALCEN (PMB)、Siemens Healthineers AG 等。这些放射治疗市场专注于新产品发布和地域扩张,以满足全球不断增长的消费者需求并增加其专业产品组合的产品范围。他们在全球范围内拥有广泛的业务,使他们能够为许多客户提供服务,从而增加他们的市场份额。该报告提供了放射治疗市场趋势分析,强调了各种参数,例如技术进步、市场动态以及全球领先市场参与者的竞争格局分析。

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is radiotherapy?

Radiotherapy is majorly used to control the growth of a tumor while restricting the harm to nearby normal and healthy tissue. Radiotherapy uses high-energy radiation, generally x-rays, to destroy the cancer cells and treat tumors in the prostate, breast, head & neck, lung, and any other parts in the body where radiation treatment is indicated.

Who are the major players in the radiotherapy market?

The radiotherapy market majorly consists of the players such as Siemens Healthineers AG, Accuray Incorporated, Sumitomo Heavy Industries, Ltd., Elekta AB, Hitachi, Ltd., Koninklijke Philips N.V., Brainlab AG, PROTOM INTERNATIONAL, Varian Medical Systems, Inc., Maastro, and Mevion Medical Systems amongst others.

What are the driving factors for the radiotherapy market across the globe?

The growth of the market is attributed to a few key driving factors such as increasing prevalence of cancer and rising number of conferences and symposiums to boost the awareness about radiation therapy. However, increased risk of adverse effects due to radiation therapy restrains the market growth.

The List of Companies - Radiotherapy Market

  1. Siemens Healthineers AG
  2. Accuray Incorporated
  3. Sumitomo Heavy Industries, Ltd.
  4. Elekta AB
  5. Hitachi, Ltd.
  6. Koninklijke Philips N.V.
  7. Brainlab AG
  8. PROTOM INTERNATIONAL
  9. Varian Medical Systems, Inc.
  10. Maastro
  11. Mevion Medical Systems

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports